Patient outcomes and amotosalen/UVA-treated platelet utilization in massively transfused patients
Author:
Affiliation:
1. Central Institute for Blood Transfusion and Immunology; Medical University Hospital Innsbruck; Innsbruck Austria
2. Cerus Corporation; Concord CA USA
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12489/fullpdf
Reference23 articles.
1. Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre;Amato;Vox Sang,2016
2. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria;Lin;Transfusion,2004
3. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light;Lin;Transfusion,2005
4. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial;McCullough;Blood,2004
5. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion;Lozano;Br J Haematol,2011
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Platelet Pathogen Reduction Technology—Should We Stay or Should We Go…?;Journal of Clinical Medicine;2024-09-10
2. Aplasies médullaires sévères acquises dans les pays émergents : prise en charge dès l’indication de l’allogreffe de cellules souches hématopoïétiques jusqu’au suivi postgreffe (SFGM-TC);Bulletin du Cancer;2024-09
3. Biochemical and functional characteristics of stored (double‐dose) buffy‐coat platelet concentrates treated with amotosalen and a prototype UVA light‐emitting diode illuminator;Transfusion;2023-08-24
4. Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center;Oncology Research and Treatment;2023
5. Evaluation of amotosalen and UVA pathogen ‐reduced apheresis platelets after 7‐day storage;Transfusion;2022-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3